- Home
- THH vs SGMT Comparison
THH vs SGMT Comparison
Compare THH & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THH
- SGMT
- Stock Information
- Founded
- THH 2013
- SGMT 2006
- Country
- THH Japan
- SGMT United States
- Employees
- THH N/A
- SGMT N/A
- Industry
- THH
- SGMT
- Sector
- THH
- SGMT
- Exchange
- THH Nasdaq
- SGMT Nasdaq
- Market Cap
- THH 270.5M
- SGMT 230.3M
- IPO Year
- THH 2025
- SGMT 2023
- Fundamental
- Price
- THH $4.56
- SGMT $7.25
- Analyst Decision
- THH
- SGMT Strong Buy
- Analyst Count
- THH 0
- SGMT 7
- Target Price
- THH N/A
- SGMT $26.57
- AVG Volume (30 Days)
- THH 715.5K
- SGMT 587.3K
- Earning Date
- THH 01-01-0001
- SGMT 08-13-2025
- Dividend Yield
- THH N/A
- SGMT N/A
- EPS Growth
- THH N/A
- SGMT N/A
- EPS
- THH 0.02
- SGMT N/A
- Revenue
- THH $20,390,561.00
- SGMT N/A
- Revenue This Year
- THH N/A
- SGMT N/A
- Revenue Next Year
- THH N/A
- SGMT N/A
- P/E Ratio
- THH $292.44
- SGMT N/A
- Revenue Growth
- THH 14.93
- SGMT N/A
- 52 Week Low
- THH $4.24
- SGMT $1.73
- 52 Week High
- THH $12.00
- SGMT $11.41
- Technical
- Relative Strength Index (RSI)
- THH N/A
- SGMT 41.01
- Support Level
- THH N/A
- SGMT $7.13
- Resistance Level
- THH N/A
- SGMT $7.68
- Average True Range (ATR)
- THH 0.00
- SGMT 0.57
- MACD
- THH 0.00
- SGMT -0.02
- Stochastic Oscillator
- THH 0.00
- SGMT 34.06
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.